Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Jerome

P1.01-87 a Phase 1b Study of TRC105 in Combination With Paclitaxel/Carboplatin and Bevacizumab in Patients With Stage 4 Non-Squamous Cell Lung Cancer

Journal of Thoracic Oncology

English

Sequence-Level and Dual-Phase Identification of Salmonella Flagellum Antigens by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)

Journal of Clinical Microbiology

Microbiology

2014

English

Related publications

Randomized Phase II Study of Cetuximab and Bevacizumab in Combination With Two Regimens of Paclitaxel and Carboplatin in Chemonaive Patients With Stage IIIB/IV Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology

English

A Phase Ib/Ii Study of HER3-targeting Lumretuzumab in Combination With Carboplatin and Paclitaxel as First-Line Treatment in Patients With Advanced or Metastatic Squamous Non-Small Cell Lung Cancer

English

Pcn197 - Cost Utility Analysis of First-Line Paclitaxel With Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab Versus Pemetrexed With Carboplatin Followed by Maintenance Pemetrexed in Patients With Advanced Non-Squamous Non-Small-Cell Lung Cancer in Lebanon

English

Induction of Peripheral Effector CD8 T Cell Proliferation by Combination of Paclitaxel, Carboplatin and Bevacizumab in Non-Small Cell Lung Cancer Patients

Clinical Cancer Research

Cancer Research

Oncology

2019

English

Sex Differences in Outcome With Bevacizumab Therapy: Analysis of Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With or Without Bevacizumab in Combination With Paclitaxel and Carboplatin in the Eastern Cooperative Oncology Group Trial 4599

Journal of Thoracic Oncology

English

P1.01-76 a Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients With Newly Diagnosed Stage IV Squamous Cell Lung Cancers

Journal of Thoracic Oncology

English

Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Squamous Non–Small-Cell Lung Cancer: Results From the Randomized Controlled MONET1 Study

Journal of Thoracic Oncology

English

Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients With Extensive-Stage Small-Cell Lung Cancer

Journal of Thoracic Oncology

English

Phase I Study of Paclitaxel and Carboplatin Combination Chemotherapy for Elderly Patients Aged 75 Years and Over With Advanced Non-Small Cell Lung Cancer

Japanese Journal of Lung Cancer

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Jerome

P1.01-87 a Phase 1b Study of TRC105 in Combination With Paclitaxel/Carboplatin and Bevacizumab in Patients With Stage 4 Non-Squamous Cell Lung Cancer

Sequence-Level and Dual-Phase Identification of Salmonella Flagellum Antigens by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)

Related publications

Randomized Phase II Study of Cetuximab and Bevacizumab in Combination With Two Regimens of Paclitaxel and Carboplatin in Chemonaive Patients With Stage IIIB/IV Non–Small-Cell Lung Cancer

A Phase Ib/Ii Study of HER3-targeting Lumretuzumab in Combination With Carboplatin and Paclitaxel as First-Line Treatment in Patients With Advanced or Metastatic Squamous Non-Small Cell Lung Cancer

Pcn197 - Cost Utility Analysis of First-Line Paclitaxel With Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab Versus Pemetrexed With Carboplatin Followed by Maintenance Pemetrexed in Patients With Advanced Non-Squamous Non-Small-Cell Lung Cancer in Lebanon

Induction of Peripheral Effector CD8 T Cell Proliferation by Combination of Paclitaxel, Carboplatin and Bevacizumab in Non-Small Cell Lung Cancer Patients

Sex Differences in Outcome With Bevacizumab Therapy: Analysis of Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With or Without Bevacizumab in Combination With Paclitaxel and Carboplatin in the Eastern Cooperative Oncology Group Trial 4599

P1.01-76 a Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients With Newly Diagnosed Stage IV Squamous Cell Lung Cancers

Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Squamous Non–Small-Cell Lung Cancer: Results From the Randomized Controlled MONET1 Study

Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients With Extensive-Stage Small-Cell Lung Cancer

Phase I Study of Paclitaxel and Carboplatin Combination Chemotherapy for Elderly Patients Aged 75 Years and Over With Advanced Non-Small Cell Lung Cancer